PhaseLite™ works without exerting any pharmacological, immunological or metabolic action or effects on the human body

PhaseLite™ is naturally derived, drug-free and categorised as GRAS (Generally Regarded As Safe) with no known side effects. In the clinical studies reviewed there were no reports of serious side effects resulting from the ingestion of PhaseLite™. Furthermore, in over 2 billion doses sold to date, there were no serious adverse events recorded.

Hence, based on animal studies, human clinical studies and market history, the use of PhaseLite™, is proven to be safe, and does not pose an unjustifiable risk for its intended indications.

PhaseLite™ blocks carbohydrates without any pharmacological, immunological or metabolic action or effects on the human body. As a result of this non-systemic mode of action, products made with PhaseLite™ are certified as a medical device* under the Medical Device Directive 93/42/EEC.


* What is a Medical Device?

A medical device is amongst others defined as any article, whether used alone or in combination, intended by the manufacturer to be used for human beings for the purpose of: prevention, monitoring, treatment or alleviation of disease and which achieves its principal intended action in or on the human body, not through any pharmacological, immunological or metabolic means, but which may be assisted in its function by such means.



Previous | Next

 
Copyright © 2015 by InQpharm Group. All rights reserved. Last updated: Oct 2015 | ID: MP/TM/EN/15/001
Phaselite and InQpharm are trademarks of the InQpharm group of companies.